2 COVID-19 vaccines passed pre-evaluation, according to a DOH official.
A health official on Thursday said that the vaccine experts panel and ethics review board of the Department of Health (DOH) had approved clinical trial applications of two COVID-19 vaccines.
This, as it cleared the way for final evaluation by the Food and Drug Administration (FDA).
During a virtual briefing, Health Undersecretary Maria Rosario Vergeire said that for those approved by both vaccine experts panel and ethics review board like Clover and Janssen, they would go through the FDA process already and they would await for the information to be given to them by the Food and Drug Administration.
Clover Biopharmaceuticals was a Chinese company, while Janssen Pharmaceuticals was under a multinational giant Johnson & Johnson.
Both Clover and Janssen were applying to run clinical trials in the Philippines for their vaccines against coronavirus disease.
Aside from Clover and Janssen, AstraZeneca was cleared by the ethics review board, while Sinovac had already passed the vaccine expert panel.
AstraZeneca, meanwhile, was the only vaccine maker that had a supply deal with the Philippines through a private sector. Gamaleya Institute — which had yet to complete its requirements for application — was also being considered by the country.
Other vaccine makers were Moderna and Pfizer-BioNTech, which both showed high efficacy rates according to initial trials.
The Department of Health also said that it couldn’t say yet if Moderna and Pfizer-BioNTech were applying for clinical trials or supply deals in the Philippines.